Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Polgár

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Acta Biologica Hungarica|October 10, 2002
A synthetic corticosteroid, dexamethasone regulates generation of soluble form of interleukin-6 receptor of human lymphocytes, in vitroAnna Polgár, Márta Brózik, Sára Tóth, et al.
Orvosi Hetilap|April 6, 2025
[Interdisciplinary consensus statement about the diagnosis and treatment of chronic fatigue syndrome/myalgic encephalomyelopathy]Gábor Simonyi, J Róbert Bedros, János Réthelyi, et al.
International Immunology|September 11, 2012
Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patientsMariann Kremlitzka, Anna Polgár, Lívia Fülöp, et al.
Journal of Immunology Research|December 17, 2016
Complement Receptor Type 1 Suppresses Human B Cell Functions in SLE PatientsMariann Kremlitzka, Bernadett Mácsik-Valent, Anna Polgár, et al.
Immunology Letters|May 15, 2002
Soluble interleukin-6 receptor enhanced by oncostatin M induces major changes in gene expression profile of human hepatoma cellsMarianna Csilla Holub, Hargita Hegyesi, Peter Igaz, et al.
Autoimmunity Reviews|October 6, 2010
Devic's syndrome and SLE: challenges in diagnosis and therapeutic possibilities based on two overlapping casesAnna Polgár, Csilla Rózsa, Veronika Müller, et al.
Rheumatology (Oxford, England)|June 24, 2010
Cost-of-illness of patients with systemic sclerosis in a tertiary care centreTünde Minier, Márta Péntek, Valentin Brodszky, et al.
Rheumatology International|April 22, 2009
Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experimentValentin Brodszky, Péter Bálint, Pál Géher, et al.
Orvosi Hetilap|April 23, 2008
[Impact of disease progression on health status, quality of life and costs in rheumatoid arthritis in Hungary]Márta Péntek, Zoltán Szekanecz, László Czirják, et al.
Arthritis Research & Therapy|September 16, 2008
Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritisBence György, László Tóthfalusi, György Nagy, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Acta Biologica Hungarica|October 10, 2002
A synthetic corticosteroid, dexamethasone regulates generation of soluble form of interleukin-6 receptor of human lymphocytes, in vitroAnna Polgár, Márta Brózik, Sára Tóth, et al.
Orvosi Hetilap|April 6, 2025
[Interdisciplinary consensus statement about the diagnosis and treatment of chronic fatigue syndrome/myalgic encephalomyelopathy]Gábor Simonyi, J Róbert Bedros, János Réthelyi, et al.
International Immunology|September 11, 2012
Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patientsMariann Kremlitzka, Anna Polgár, Lívia Fülöp, et al.
Journal of Immunology Research|December 17, 2016
Complement Receptor Type 1 Suppresses Human B Cell Functions in SLE PatientsMariann Kremlitzka, Bernadett Mácsik-Valent, Anna Polgár, et al.
Immunology Letters|May 15, 2002
Soluble interleukin-6 receptor enhanced by oncostatin M induces major changes in gene expression profile of human hepatoma cellsMarianna Csilla Holub, Hargita Hegyesi, Peter Igaz, et al.
Autoimmunity Reviews|October 6, 2010
Devic's syndrome and SLE: challenges in diagnosis and therapeutic possibilities based on two overlapping casesAnna Polgár, Csilla Rózsa, Veronika Müller, et al.
Rheumatology (Oxford, England)|June 24, 2010
Cost-of-illness of patients with systemic sclerosis in a tertiary care centreTünde Minier, Márta Péntek, Valentin Brodszky, et al.
Rheumatology International|April 22, 2009
Disease burden of psoriatic arthritis compared to rheumatoid arthritis, Hungarian experimentValentin Brodszky, Péter Bálint, Pál Géher, et al.
Orvosi Hetilap|April 23, 2008
[Impact of disease progression on health status, quality of life and costs in rheumatoid arthritis in Hungary]Márta Péntek, Zoltán Szekanecz, László Czirják, et al.
Arthritis Research & Therapy|September 16, 2008
Natural autoantibodies reactive with glycosaminoglycans in rheumatoid arthritisBence György, László Tóthfalusi, György Nagy, et al.
Pageof 2